MedBen Blog

Keeping You Informed.
get started

Where TrumpRx Can Add Value for Self-Funded Pharmacy Plans

The February 5th launch of the TrumpRx.gov online portal has generated attention for its lower prescription drug pricing… and may offer value for self-funded pharmacy plans in cases where medications are excluded from coverage or members face high upfront costs. While...

read more

Cancer Survival Reaches Historic Milestone

The fight against cancer has reached a major turning point. According to the American Cancer Society (ACS), seven in 10 people diagnosed with cancer in the U.S. now survive at least five years — a milestone that reflects decades of progress in prevention, detection,...

read more

Federal Actions Put PBMs Under the Microscope

Pharmacy benefit managers continue to draw scrutiny in Washington, and two recent federal actions signal that greater transparency and oversight may be on the horizon. One is a newly enacted funding law that includes PBM reforms, and the other is a proposed Department...

read more

Forensic Claims Review Delivers Record Savings in 2025

$22.38 per employee per monthThat’s the average savings MedBen clients realized in 2025 through forensic claims review — the largest annual per-employee impact since the service launched in 2007. Savings like these don’t happen by accident — or by auto-adjudication....

read more

PBM GPOs: Unmasking the Middlemen’s Middlemen

An extensive investigation by Hunterbrook Media sheds new light on how the nation’s three largest PBMs may be using little-known affiliated entities – effectively middlemen to the middlemen — to quietly retain billions of dollars that employers and health plans never...

read more

MedBen 2025 Client Satisfaction Survey Results

OVERALL SATISFACTION(based on a 1-to-5 scale)4.7 KEY METRICS Claims Payment Accuracy4.8Claims Payment Turnaround4.7Client Services4.8Account Management Courtesy & Professionalism5.0 Thank you to the clients who shared their input through MedBen’s 2025 Client...

read more

Over 350 Brand-Name Drugs See a Price Increase in 2026

Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...

read more

Why This Flu Season Matters More Than Most

Earlier this fall, we shared a reminder about the importance of annual flu vaccination and early-season planning. That guidance still holds – but this year’s flu season has raised the stakes. According to the CDC, flu activity has reached its highest level in...

read more